Imaging Tau in Atypical Parkinsonisms: Meta-Analysis of in vivo PET Imaging Findings
Objective: To determine the most accurate and reliable tau PET tracers for providing differential diagnosis of PSP and CBD from PD. Background: Parkinsonism is classified…SARS-CoV-2 Infection and Spinocerebellar Ataxia 12: Demographics, Outcomes and Post- COVID Spectrum
Objective: We aimed to assess the symptoms and long-term symptoms in spinocerebellar ataxia 12 (SCA12) COVID-19 patients. Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…Aberrant visual-related networks in familial cortical myoclonic tremor with epilepsy
Objective: To explore the mechanism of prominent visual-related symptoms and photosensitivity, and to investigate alterations of local brain activity and visual-related networks using resting-state functional magnetic…Long-term efficacy of unilateral high-intensity focused ultrasound subthalamotomy for Parkinson’s Disease
Objective: To explore the long-term safety and efficacy of focused ultrasound subthalamotomy (FUS-STN). Background: Unilateral MRI-guided high-intensity FUS-STN improves motor signs of Parkinson’s disease (PD) [1]…Mindfulness based program for newly diagnosed Parkinson’s patients.
Objective: To investigate the impact of 8-week course of Mindfulness based intervention program on motor and or non-motor symptoms of PD assessed by improvement in…Optimizing patient-centric clinical outcome assessments for use in Parkinson’s disease clinical trials: Critical Path for Parkinson’s multistakeholder initiative
Objective: To advance patient-centric endpoints for use in early-stage Parkinson’s disease (PD) clinical trials. Background: Limitations with currently available patient-centric clinical outcome assessments (COAs) has…Milder presentation in two compound heterozygote cases of spastic paraplegias type 5
Objective: Describing two mild compound heterozygote SPG5A cases. Background: Hereditary spastic paraplegia type 5 (SPG5A) is an autosomal recessive neurodegenerative disease caused by variants in…Factors related to the antidepressant effect of safinamide in Parkinson’s disease. A post-hoc analysis of SADNESS-PD study
Objective: To assess the role of different factors in the antidepressant effect of safinamide in Parkinson’s disease (PD) Background: SADNESS-PD was a real-life, multicenter, retrospective…Apathy and Volume of Tissue Activated (VTA) following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Cohort
Objective: To determine frequency and/or predictors of improvement or worsening of apathy, we evaluated this behavior among those who received bilateral subthalamic deep brain stimulation…Metabolic Biomarkers of Parkinson’s Disease in Peripheral Tissue
Objective: The goal of this study was to use magnetic resonance spectroscopy (MRS) to test whether muscles of individuals with Parkinson’s disease (PD) possess a…
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 153
- Next Page »